139 related articles for article (PubMed ID: 35619254)
1. Development of Simple Dissolution Methods for Felodipine and Combined Amlodipine Besylate-Indapamide Extended Release Tablets without Stationary (Felodipine) Basket.
Javed A; Kanwal U; Gilani SAN; Akhtar F; Shamim R; Abbas N; Bukhari NI
Curr Pharm Des; 2022; 28(24):2010-2021. PubMed ID: 35619254
[TBL] [Abstract][Full Text] [Related]
2. A better dissolution method for ranitidine tablets USP.
Cappola ML
Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
[TBL] [Abstract][Full Text] [Related]
3.
Medina-López R; Guillén-Moedano S; Hurtado M
ADMET DMPK; 2020; 8(4):411-423. PubMed ID: 35300193
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of floating and sticking extended release delivery systems: an unconventional dissolution test.
Dürig T; Fassihi R
J Control Release; 2000 Jun; 67(1):37-44. PubMed ID: 10773327
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro dissolution profiles of modified-release metoprolol succinate tablets crushed using mortar and pestle technique.
Kir F; Al-Sulaiti FK; Sahin S
Eur J Pharm Sci; 2024 Mar; 194():106694. PubMed ID: 38191064
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different Apparatuses and Dissolution Conditions.
Skripnik KKS; Riekes MK; Pezzini BR; Cardoso SG; Stulzer HK
AAPS PharmSciTech; 2017 Jul; 18(5):1785-1794. PubMed ID: 27800567
[TBL] [Abstract][Full Text] [Related]
7. Potential Application of USP Paddle and Basket Dissolution Methods in Discriminating for Portioned Moist Snuff and Snus Smokeless Tobacco Products.
Rahman Z; Dharani S; Khuroo T; Khan MA
AAPS PharmSciTech; 2021 Jan; 22(1):51. PubMed ID: 33459904
[TBL] [Abstract][Full Text] [Related]
8. Design of a novel bilayered gastric mucoadhesive system for localized and unidirectional release of lamotrigine.
Mohana Raghava Srivalli K; Lakshmi PK; Balasubramaniam J
Saudi Pharm J; 2013 Jan; 21(1):45-52. PubMed ID: 24109205
[TBL] [Abstract][Full Text] [Related]
9. Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.
Basalious EB; El-Sebaie W; El-Gazayerly O
AAPS PharmSciTech; 2011 Sep; 12(3):799-810. PubMed ID: 21701960
[TBL] [Abstract][Full Text] [Related]
10. Effect of basket mesh size on the hydrodynamics of a partially filled (500 mL) USP rotating basket dissolution testing Apparatus 1.
Sirasitthichoke C; Patel S; Reuter KG; Hermans A; Bredael G; Armenante PM
Int J Pharm; 2024 Jun; 658():124209. PubMed ID: 38718973
[TBL] [Abstract][Full Text] [Related]
11. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.
Yaro P; He X; Liu W; Xun M; Ma Y; Li Z; Shi X
Drug Dev Ind Pharm; 2014 Dec; 40(12):1670-6. PubMed ID: 24102615
[TBL] [Abstract][Full Text] [Related]
12. Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine.
Ali J; Zgair A; Hameed GS; Garnett MC; Roberts CJ; Burley JC; Gershkovich P
Int J Pharm; 2019 Jan; 555():228-236. PubMed ID: 30465852
[TBL] [Abstract][Full Text] [Related]
13. Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug.
Vetchy D; Vetcha M; Rabiskova M; Gryczova E; Bartosikova L
Medicina (Kaunas); 2007; 43(4):326-31. PubMed ID: 17485960
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
Breier AR; Paim CS; Steppe M; Schapoval EE
J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
[TBL] [Abstract][Full Text] [Related]
15. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
Qureshi SA; McGilveray IJ
Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
[TBL] [Abstract][Full Text] [Related]
16. Dissolution testing of acetylsalicylic acid by a channel flow method-correlation to USP basket and intrinsic dissolution methods.
Peltonen L; Liljeroth P; Heikkilä T; Kontturi K; Hirvonen J
Eur J Pharm Sci; 2003 Aug; 19(5):395-401. PubMed ID: 12907290
[TBL] [Abstract][Full Text] [Related]
17. Influence of dissolution medium agitation on release profiles of sustained-release tablets.
Paulo ; Sousa Lobo JM
Drug Dev Ind Pharm; 2001 Sep; 27(8):811-7. PubMed ID: 11699832
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Hydrodynamics in the USP Basket Apparatus Using Computational Fluid Dynamics.
Martinez AF; Sinha K; Nere N; Slade R; Castleberry S
J Pharm Sci; 2020 Mar; 109(3):1231-1241. PubMed ID: 31743682
[TBL] [Abstract][Full Text] [Related]
20. Development of USP Apparatus 3 Dissolution Method with IVIVC for Extended Release Tablets of Metformin Hydrochloride and Development of a Generic Formulation.
Mendes TC; Simon A; Menezes JCV; Pinto EC; Cabral LM; de Sousa VP
Chem Pharm Bull (Tokyo); 2019; 67(1):23-31. PubMed ID: 30606948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
